| Christopher P Demas, MD | |
|
2211 Lomas Blvd Ne, Albuquerque, NM 87106-2745 | |
| (505) 272-4264 | |
| (505) 272-1669 |
| Full Name | Christopher P Demas |
|---|---|
| Gender | Male |
| Speciality | Plastic Surgery |
| Location | 2211 Lomas Blvd Ne, Albuquerque, New Mexico |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083634265 | NPI | - | NPPES |
| 03255061 | Medicaid | NY | |
| 0RE5815 | Medicaid | VT | |
| 30201032 | Medicaid | NH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | MD2013-0191 (New Mexico) | Primary |
| Entity Name | Unm Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831218627 PECOS PAC ID: 4981795267 Enrollment ID: O20070801000589 |
News Archive
The effective use of contraception once becoming sexually active is the best way to avoid unwanted pregnancy during adolescence. This is just one of the conclusions of a study by the Spanish National Research Council and the Universidad Complutense in Madrid which additionally reveals that using no contraception or using it well after starting sexual relations increases up to six times the risk for teen pregnancy.
Life Technologies Corporation today announced it has completed and settled the previously announced offering of $250 million aggregate principal amount of 3.375% Senior Notes due 2013 at an issue price of 99.953 percent; $500 million aggregate principal amount of 4.400% Senior Notes due 2015 at an issue price of 99.668 percent; and $750 million aggregate principal amount of 6.000% Senior Notes due 2020 at an issue price of 99.796 percent. The notes will pay interest on a semi-annual basis.
A review of more than 80 studies reveals that changes in the immune cells of people with human immunodeficiency virus (HIV) infection may increase their risk of cardiovascular disease (CVD). The review is published in the journal Physiology.
Takeda Pharmaceutical Company Limited and URL Pharma Inc. jointly announced that Takeda's wholly-owned subsidiary, Takeda America Holdings, Inc. and URL Pharma have entered into a definitive agreement to acquire URL Pharma – a privately-held pharmaceutical company headquartered in Philadelphia, Pennsylvania, for an upfront payment of $800 million and future performance-based contingent earn out payments.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christopher P Demas, MD 2211 Lomas Blvd Ne, Albuquerque, NM 87106-2745 Ph: (505) 272-3120 | Christopher P Demas, MD 2211 Lomas Blvd Ne, Albuquerque, NM 87106-2745 Ph: (505) 272-4264 |
News Archive
The effective use of contraception once becoming sexually active is the best way to avoid unwanted pregnancy during adolescence. This is just one of the conclusions of a study by the Spanish National Research Council and the Universidad Complutense in Madrid which additionally reveals that using no contraception or using it well after starting sexual relations increases up to six times the risk for teen pregnancy.
Life Technologies Corporation today announced it has completed and settled the previously announced offering of $250 million aggregate principal amount of 3.375% Senior Notes due 2013 at an issue price of 99.953 percent; $500 million aggregate principal amount of 4.400% Senior Notes due 2015 at an issue price of 99.668 percent; and $750 million aggregate principal amount of 6.000% Senior Notes due 2020 at an issue price of 99.796 percent. The notes will pay interest on a semi-annual basis.
A review of more than 80 studies reveals that changes in the immune cells of people with human immunodeficiency virus (HIV) infection may increase their risk of cardiovascular disease (CVD). The review is published in the journal Physiology.
Takeda Pharmaceutical Company Limited and URL Pharma Inc. jointly announced that Takeda's wholly-owned subsidiary, Takeda America Holdings, Inc. and URL Pharma have entered into a definitive agreement to acquire URL Pharma – a privately-held pharmaceutical company headquartered in Philadelphia, Pennsylvania, for an upfront payment of $800 million and future performance-based contingent earn out payments.
› Verified 3 days ago
Richard Charles Gobeille, M. D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2601 Wyoming Blvd Ne, Suite 205, Albuquerque, NM 87112 Phone: 505-856-1619 | |
Neil T Chen, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3830 Masthead Street Ne, Albuquerque, NM 87109 Phone: 505-842-8889 Fax: 505-842-8886 | |
Cesar Luis Cuadros, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 8232 Louisiana Blvd Ne Ste A, Albuquerque, NM 87113 Phone: 505-243-7670 Fax: 505-242-0510 | |
Dr. Ryan P. Kunkel, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5203 Juan Tabo Blvd Ne Ste 1c, Albuquerque, NM 87111 Phone: 505-299-4900 | |
Jon Dagley Wagner, MD DDS Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 10000 Coors Byp Nw, Suite G-218, Albuquerque, NM 87114 Phone: 505-242-4867 | |
Anil Shetty, Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2211 Lomas Blvd Ne, University Of New Mexico Health Sciences Center, Albuquerque, NM 87106 Phone: 505-272-5504 Fax: 505-272-1669 |